Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,372 | -8,410 | -4,503 | -9,920 | -15,160 |
| Depreciation Amortization | 433 | 287 | 141 | 780 | 940 |
| Accounts payable and accrued liabilities | 717 | 430 | -180 | N/A | N/A |
| Other Working Capital | 1,718 | 655 | 181 | -500 | -230 |
| Other Operating Activity | 4,255 | 2,018 | 2,022 | 740 | 2,820 |
| Operating Cash Flow | $-8,249 | $-5,020 | $-2,339 | $-8,900 | $-11,630 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -846 | -317 | -58 | -50 | -550 |
| Investing Cash Flow | $-846 | $-317 | $-58 | $-50 | $-550 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,351 | 11,605 | 11,605 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 12,040 | 7,280 |
| Financing Cash Flow | $17,351 | $11,605 | $11,605 | $12,040 | $7,280 |
| Exchange Rate Effect | -4 | -103 | -86 | -1 | 0 |
| Beginning Cash Position | 7,244 | 7,244 | 4,167 | 4,160 | 9,060 |
| End Cash Position | 15,496 | 13,409 | 13,289 | 7,240 | 4,160 |
| Net Cash Flow | $8,252 | $6,165 | $9,122 | $3,070 | $-4,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,249 | -5,020 | -2,339 | -8,900 | -11,630 |
| Capital Expenditure | -846 | -317 | -58 | N/A | N/A |
| Free Cash Flow | -9,095 | -5,337 | -2,397 | -8,900 | -11,630 |